EPG Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-483
Closed -$244K 447
2023
Q3
$244K Sell
483
-1,866
-79% -$994K 0.07% 215
2023
Q2
$1.23M Buy
2,349
+165
+8% +$89K 0.36% 70
2023
Q1
$1.26M Buy
2,184
+966
+79% +$544K 0.4% 68
2022
Q4
$671K Sell
1,218
-8
-0.7% -$4.24K 0.26% 92
2022
Q3
$622K Buy
1,226
+84
+7% +$47K 0.26% 90
2022
Q2
$620K Buy
1,142
+5
+0.4% +$2.75K 0.26% 85
2022
Q1
$672K Buy
1,137
+165
+17% +$94.8K 0.23% 90
2021
Q4
$649K Buy
972
+87
+10% +$54.3K 0.23% 92
2021
Q3
$506K Buy
885
+139
+19% +$76.3K 0.2% 104
2021
Q2
$376K Buy
746
+21
+3% +$9.91K 0.16% 131
2021
Q1
$331K Buy
725
+57
+9% +$27.2K 0.16% 133
2020
Q4
$311K Buy
+668
New +$313K 0.19% 106
2020
Q2
Sell
-322
Closed -$91K 699
2020
Q1
$91K Sell
322
-405
-56% -$128K 0.07% 185
2019
Q4
$236K Buy
+727
New +$220K 0.17% 87

Other funds holding TMO

EPG Wealth Management's TMO Position: Q4 2023 in Review

EPG Wealth Management sold out of Thermo Fisher Scientific (TMO) in Q4 2023, closing a stake of 483 shares — an estimated $244K sold.

EPG Wealth Management first reported a position in TMO in Q4 2019 and held it in 14 quarters. The position peaked at $1.26M in Q1 2023. 2,491 funds tracked by Wall St. Rank hold TMO as of Q4 2023.

  • EPG Wealth Management reported no remaining Thermo Fisher Scientific position as of Q4 2023 after selling out during the quarter.
  • EPG Wealth Management sold 483 Thermo Fisher Scientific shares in Q4 2023, an estimated $244K.
  • EPG Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 14 quarters.
  • EPG Wealth Management's Thermo Fisher Scientific position peaked at $1.26M in Q1 2023.
  • 2,491 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2023.

Based on EPG Wealth Management's 13F filing for Q4 2023, filed 15 Feb 2024.